Industry reports
Editor highlights

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Pathology Analysis & Statistics, February 2014 (p5)

You might be interested in: cancer, breast cancer, prostate cancer, more »

» Purchase Premium Reports

121-170 of about 5 600 reports
Crohn's Disease - Pipeline Review, H1 2014

Crohn's Disease - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Crohn's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Crohn's Disease - Pipeline Review, H1 2014', provides an overview of the Crohn's Disease's therapeutic pipeline. This report ...

  • Industries : Pathology
Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2014

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2014', provides an overview of the Metastatic Renal ...

  • Industries : Pathology
  • Countries : World
World Drug and Medication: Malignant Mesothelioma – Pipeline Review, H1 2012

World Drug and Medication: Malignant Mesothelioma – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides information on the therapeutic development for Malignant Mesothelioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

  • Industries : Pathology
  • Countries : World
Epithelial Ovarian Cancer - Pipeline Review, H1 2014

Epithelial Ovarian Cancer - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Epithelial Ovarian Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2014', provides an overview of the Epithelial Ovarian Cancer's therapeutic ...

  • Industries : Pathology
  • Countries : World, United States
World Pathology: Vulvovaginal Candidiasis – Pipeline Review, H1 2012

World Pathology: Vulvovaginal Candidiasis – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides information on the therapeutic development for Vulvovaginal Candidiasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

  • Industries : Pathology
  • Countries : World
Drug and Medication in Japan: Dyslipidemia – Pipeline Review, H1 2012

Drug and Medication in Japan: Dyslipidemia – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Dyslipidemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Pathology
  • Countries : World
World Pathology: Hypercholesterolemia – Pipeline Review, H1 2012

World Pathology: Hypercholesterolemia – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Hypercholesterolemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Pathology
  • Countries : United States, World
Pulmonary Hypertension - Pipeline Review, H1 2014

Pulmonary Hypertension - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Pulmonary Hypertension - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Pulmonary Hypertension - Pipeline Review, H1 2014', provides an overview of the Pulmonary Hypertension's therapeutic ...

  • Industries : Pathology
  • Countries : World, United States
Huntington's Disease - Pipeline Review, H1 2014

Huntington's Disease - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Huntington's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Huntington's Disease - Pipeline Review, H1 2014', provides an overview of the Huntington's Disease's therapeutic pipeline. ...

  • Industries : Pathology
Pathology in United States: Metastatic Pancreatic Cancer – Pipeline Review, H1 2012

Pathology in United States: Metastatic Pancreatic Cancer – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides information on the therapeutic development for Metastatic Pancreatic Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

  • Industries : Pathology
  • Countries : World
World Drug and Medication: Rectal Cancer – Pipeline Review, H1 2012

World Drug and Medication: Rectal Cancer – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides information on the therapeutic development for Rectal Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Pathology
  • Countries : World
World Drug and Medication: Medulloblastoma – Pipeline Review, H1 2012

World Drug and Medication: Medulloblastoma – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides information on the therapeutic development for Medulloblastoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Pathology
  • Countries : World
Down Syndrome - Pipeline Review, H1 2014

Down Syndrome - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Down Syndrome - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Down Syndrome - Pipeline Review, H1 2014', provides an overview of the Down Syndrome's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World
World Pathology: Major Depressive Disorder – Pipeline Review, H1 2012

World Pathology: Major Depressive Disorder – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Major Depressive Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Pathology
  • Countries : World
Biological Therapy in United States: Cirrhosis – Pipeline Review, H1 2012

Biological Therapy in United States: Cirrhosis – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Cirrhosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Pathology
  • Countries : United States, World
Osteoarthritis Pain - Pipeline Review, H1 2014

Osteoarthritis Pain - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Osteoarthritis Pain - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Osteoarthritis Pain - Pipeline Review, H1 2014', provides an overview of the Osteoarthritis Pain's therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : United States, World
Refractory Multiple Myeloma - Pipeline Review, H1 2014

Refractory Multiple Myeloma - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Refractory Multiple Myeloma - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Refractory Multiple Myeloma - Pipeline Review, H1 2014', provides an overview of the Refractory Multiple Myeloma's ...

  • Industries : Pathology
  • Countries : World
Drug and Medication Industry: Follicular Lymphoma – Pipeline Review, H1 2012

Drug and Medication Industry: Follicular Lymphoma – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides information on the therapeutic development for Follicular Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

  • Industries : Pathology
  • Countries : United States, World
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2014

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2014', provides an overview of the ...

  • Industries : Pathology
  • Countries : World
World Drug and Medication: Epilepsy – Pipeline Review, H1 2012

World Drug and Medication: Epilepsy – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Epilepsy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...

  • Industries : Pathology
  • Countries : Australia, World
World Pathology: Respiratory Depression – Pipeline Review, H1 2012

World Pathology: Respiratory Depression – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Respiratory Depression, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Pathology
  • Countries : World
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2014

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) ...

  • Industries : Pathology
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014', provides an overview ...

  • Industries : Pathology
  • Countries : World
Pathology in United States: Diffuse Large B-Cell Lymphoma – Pipeline Review, H1 2012

Pathology in United States: Diffuse Large B-Cell Lymphoma – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides information on the therapeutic development for Diffuse Large B-Cell Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

  • Industries : Pathology
  • Countries : United States, World
B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014', provides an overview of the B-Cell Non-Hodgkin Lymphoma's ...

  • Industries : Pathology
  • Countries : World, United States
World Drug and Medication: Ewing Sarcoma – Pipeline Review, H1 2012

World Drug and Medication: Ewing Sarcoma – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides information on the therapeutic development for Ewing Sarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Pathology
  • Countries : World
World Pathology: Systemic Lupus Erythematosus – Pipeline Review, H1 2012

World Pathology: Systemic Lupus Erythematosus – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Systemic Lupus Erythematosus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

  • Industries : Pathology
Allergic Rhinitis - Pipeline Review, H1 2014

Allergic Rhinitis - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Allergic Rhinitis - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Allergic Rhinitis - Pipeline Review, H1 2014', provides an overview of the Allergic Rhinitis's therapeutic pipeline. This ...

  • Industries : Pathology
  • Countries : World
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014', provides an overview of the Plaque ...

  • Industries : Pathology
  • Countries : United States, World
Drug and Medication Industry: Fallopian Tube Cancer – Pipeline Review, H1 2012

Drug and Medication Industry: Fallopian Tube Cancer – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides information on the therapeutic development for Fallopian Tube Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

  • Industries : Pathology
  • Countries : United States, World

» View Public Reports

About 12 000 reports

The Australian Pharmaceutical Business Brief

  • Industry report
  • April 2014
  • 8 pages
  • by Corporation

... To compare the expenditure of other chronic diseases, particularly chronic diseases that share many of the same risk factors such as ckd [14]. As a result, this investigation will determine and compare ...

U.s. Diabete Sector

April 2014

» Read our Company Profiles

About 200 Companies

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

Johnson and Johnson

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.